The role of glycosylation in receptor activation

糖基化在受体激活中的作用

基本信息

  • 批准号:
    203498-2013
  • 负责人:
  • 金额:
    $ 2.19万
  • 依托单位:
  • 依托单位国家:
    加拿大
  • 项目类别:
    Discovery Grants Program - Individual
  • 财政年份:
    2013
  • 资助国家:
    加拿大
  • 起止时间:
    2013-01-01 至 2014-12-31
  • 项目状态:
    已结题

项目摘要

The nature of our research program is to study the role of sugar residues expressed by many proteins and receptors in cellular activation. These sugar residues carry out functions essential for the maintenance of biological activities of cells, including transmission of biological information between cell membrane surfaces, formation of cell morphology and maintenance of complicated physiological cell responses to stimuli. In particular, our research focuses on the receptor tyrosine kinases (RTKs) which are the cell surface receptors for many polypeptide growth factors, cytokines and hormones used by our body for normal survival. In addition, we have included the mammalian Toll-like receptors (TLRs) which are a family of receptors that recognize pathogen-associated molecular patterns. Thus, it is critical that the intensity and duration of these receptor responses to stimuli must be tightly controlled. Various reports have suggested that receptor sugar modification may in fact be the invisible link connecting receptor binding, activation and cellular responses. My HQP trainees have identified the key players linked in the hormone-induced receptor activation process(es). Neu1 sialidase was uncovered as an essential enzyme which acts through a common receptor level signaling pathway on the cell surface to regulate the activation of a number of these receptors. Although the precise relationship between Neu1 and receptor activation has yet to be fully elucidated, it represents a new or pioneering approach to cell regulation pathways that have been missed in the field. If successful, the findings would be highly significant to the entire field of receptor-mediated cellular biology. The finding that receptor sugar modifications is critical for normal cell activation has immense potential for use as research tools for HQP trainees or even in therapeutic regulation of receptor bioactivity and downstream cell physiology.
我们研究计划的性质是研究许多蛋白质和受体表达的糖残基在细胞活化中的作用。这些糖残基执行维持细胞生物活性所必需的功能,包括在细胞膜表面之间传递生物信息、形成细胞形态和维持对刺激的复杂生理细胞反应。 特别是,我们的研究集中在受体酪氨酸激酶(RTK),这是许多多肽生长因子,细胞因子和激素的细胞表面受体,我们的身体用于正常生存。此外,我们还包括哺乳动物Toll样受体(TLR),这是一个识别病原体相关分子模式的受体家族。因此,必须严格控制这些受体对刺激的反应的强度和持续时间。各种报告表明,受体糖修饰实际上可能是连接受体结合、活化和细胞反应的无形联系。我的HQP学员已经确定了与激素诱导的受体激活过程相关的关键参与者。Neu1唾液酸酶被发现是一种必需的酶,其通过细胞表面上的共同受体水平信号传导途径来调节许多这些受体的活化。虽然Neu1和受体激活之间的精确关系尚未完全阐明,但它代表了该领域错过的细胞调控途径的新方法或开创性方法。如果成功,这些发现将对整个受体介导的细胞生物学领域具有重要意义。受体糖修饰对正常细胞活化至关重要,这一发现具有巨大的潜力,可用作HQP学员的研究工具,甚至可用于受体生物活性和下游细胞生理学的治疗调节。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Szewczuk, Myron其他文献

Szewczuk, Myron的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Szewczuk, Myron', 18)}}的其他基金

Novel biased G-protein coupled receptor-signalling paradigm regulating growth factor and pathogen-sensing receptors
调节生长因子和病原体感应受体的新型偏向 G 蛋白偶联受体信号传导范式
  • 批准号:
    RGPIN-2020-03869
  • 财政年份:
    2022
  • 资助金额:
    $ 2.19万
  • 项目类别:
    Discovery Grants Program - Individual
Novel biased G-protein coupled receptor-signalling paradigm regulating growth factor and pathogen-sensing receptors
调节生长因子和病原体感应受体的新型偏向 G 蛋白偶联受体信号传导范式
  • 批准号:
    RGPIN-2020-03869
  • 财政年份:
    2021
  • 资助金额:
    $ 2.19万
  • 项目类别:
    Discovery Grants Program - Individual
Novel biased G-protein coupled receptor-signalling paradigm regulating growth factor and pathogen-sensing receptors
调节生长因子和病原体感应受体的新型偏向 G 蛋白偶联受体信号传导范式
  • 批准号:
    RGPIN-2020-03869
  • 财政年份:
    2020
  • 资助金额:
    $ 2.19万
  • 项目类别:
    Discovery Grants Program - Individual
Mechanism of CoVID-19 induced hyperinflammation
CoVID-19诱导过度炎症的机制
  • 批准号:
    550110-2020
  • 财政年份:
    2020
  • 资助金额:
    $ 2.19万
  • 项目类别:
    Alliance Grants
Novel molecular signaling platform regulating receptor activation and cell function
调节受体激活和细胞功能的新型分子信号平台
  • 批准号:
    RGPIN-2015-05301
  • 财政年份:
    2019
  • 资助金额:
    $ 2.19万
  • 项目类别:
    Discovery Grants Program - Individual
Novel molecular signaling platform regulating receptor activation and cell function
调节受体激活和细胞功能的新型分子信号平台
  • 批准号:
    RGPIN-2015-05301
  • 财政年份:
    2018
  • 资助金额:
    $ 2.19万
  • 项目类别:
    Discovery Grants Program - Individual
Novel molecular signaling platform regulating receptor activation and cell function
调节受体激活和细胞功能的新型分子信号平台
  • 批准号:
    RGPIN-2015-05301
  • 财政年份:
    2017
  • 资助金额:
    $ 2.19万
  • 项目类别:
    Discovery Grants Program - Individual
Novel molecular signaling platform regulating receptor activation and cell function
调节受体激活和细胞功能的新型分子信号平台
  • 批准号:
    RGPIN-2015-05301
  • 财政年份:
    2016
  • 资助金额:
    $ 2.19万
  • 项目类别:
    Discovery Grants Program - Individual
Novel molecular signaling platform regulating receptor activation and cell function
调节受体激活和细胞功能的新型分子信号平台
  • 批准号:
    RGPIN-2015-05301
  • 财政年份:
    2015
  • 资助金额:
    $ 2.19万
  • 项目类别:
    Discovery Grants Program - Individual
The role of glycosylation in receptor activation
糖基化在受体激活中的作用
  • 批准号:
    203498-2008
  • 财政年份:
    2012
  • 资助金额:
    $ 2.19万
  • 项目类别:
    Discovery Grants Program - Individual

相似国自然基金

miR-155调控Th1/Th2平衡及IgA糖基化在IgA肾病发病机制中的作用研究
  • 批准号:
    81270793
  • 批准年份:
    2012
  • 资助金额:
    70.0 万元
  • 项目类别:
    面上项目
胞浆或核定位蛋白质的O-GalNAc糖基化研究
  • 批准号:
    31170771
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目

相似海外基金

Role of serum advanced glycation end-products in altering tendon properties with diabetes
血清晚期糖基化终末产物在改变糖尿病肌腱特性中的作用
  • 批准号:
    10737036
  • 财政年份:
    2023
  • 资助金额:
    $ 2.19万
  • 项目类别:
Immune Modulation During Acute Lyme Disease Infection as the Result of Aberrant Immunoglobulin Glycosylation
异常免疫球蛋白糖基化导致急性莱姆病感染期间的免疫调节
  • 批准号:
    10726417
  • 财政年份:
    2023
  • 资助金额:
    $ 2.19万
  • 项目类别:
Cause and Effect Relationships Between Glycation and the Ancestry Specific Tumor Stroma
糖化与祖先特异性肿瘤基质之间的因果关系
  • 批准号:
    10586185
  • 财政年份:
    2023
  • 资助金额:
    $ 2.19万
  • 项目类别:
The impact of alcohol-induced ATF6-mediated ER stress and Golgi disorganization on pro-metastatic glycosylation of integrins in prostate cancer
酒精诱导的 ATF6 介导的 ER 应激和高尔基体解体对前列腺癌整合素促转移糖基化的影响
  • 批准号:
    10826211
  • 财政年份:
    2023
  • 资助金额:
    $ 2.19万
  • 项目类别:
Project: Survivorship Care Physical Activity Initiative to Improve Disparities in HRQoL for Prostate Cancer Survivors (RELate Study)
项目:旨在改善前列腺癌幸存者 HRQoL 差异的生存护理体力活动计划(RELate 研究)
  • 批准号:
    10911646
  • 财政年份:
    2023
  • 资助金额:
    $ 2.19万
  • 项目类别:
Elucidating the immunology of autoantibody formation and function in COVID-19
阐明 COVID-19 中自身抗体形成和功能的免疫学
  • 批准号:
    10639707
  • 财政年份:
    2023
  • 资助金额:
    $ 2.19万
  • 项目类别:
Age-Dependent N-Glycosylation of Follicle-Stimulation Hormone in Gonadotropes
促性腺激素中卵泡刺激激素的年龄依赖性 N-糖基化
  • 批准号:
    10679254
  • 财政年份:
    2023
  • 资助金额:
    $ 2.19万
  • 项目类别:
Synaptic dysglycosylation caused by the schizophrenia-risk variant in SLC39A8
SLC39A8 中精神分裂症风险变异引起的突触糖基化异常
  • 批准号:
    10671675
  • 财政年份:
    2023
  • 资助金额:
    $ 2.19万
  • 项目类别:
Molecular analysis of SORL1 function and dysfunction in Alzheimer's disease
阿尔茨海默病中 SORL1 功能和功能障碍的分子分析
  • 批准号:
    10661159
  • 财政年份:
    2023
  • 资助金额:
    $ 2.19万
  • 项目类别:
The TGF-Beta/MUC4 Signaling Axis in Circulating Tumor Cells of Metastatic Breast Cancer
转移性乳腺癌循环肿瘤细胞中的 TGF-β/MUC4 信号轴
  • 批准号:
    10751169
  • 财政年份:
    2023
  • 资助金额:
    $ 2.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了